Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Report Overview
2023
Base Year
2018-2023
Historical Year
2024-2032
Forecast Year
Alopecia Areata Market Analysis
The market growth is driven by the increasing incidence of alopecia areata. The market is further influenced by latest FDA approvals for drugs effective in alopecia treatment. For example, the leading pharmaceutical company, Pfizer Inc., received approval from the U.S. Food and Drug Administration (FDA) for LITFULO™ (ritlecitinib), a once-daily oral treatment, for individuals 12 years of age and older with severe alopecia areata. The approved recommended dose for LITFULO is 50 mg. As it is the one and only FDA approved treatment available, the demand for LITFULO™ is expected to witness a surge in the market. Being the only FDA approved treatment available in the market, it holds the maximum advantage over the Olumiant by Eli Lilly as it covers a wider range of patients. With high demand and widespread market reach the alopecia areata market demand is expected to witness an upward trajectory in the forecast period.
Additionally, Sun Pharmaceutical Industries Ltd. recently declared the acceptance of the new drug application for deuruxolitinib by the U.S. health regulator. This is an investigational oral drug for the treatment of adults with moderate to severe alopecia areata. If approved, this could significantly impact the market by providing an alternative for patients who might not have responded well to existing treatments. Moreover, the introduction of a new drug in the alopecia treatment market could intensify competition, and further contribute to market growth.
Alopecia Areata Market Report Snapshots
Alopecia Areata Treatment Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Key Questions Answered in the Report
The market is anticipated to grow at a CAGR of 6.3% during the forecast period of 2024-2032.
The increasing awareness about alopecia areata, along with the rising research and development activities, are some of the major factors driving the market growth.
The FDA approving drugs for the treatment of conditions is a major trend influencing the market growth.
The 7 major regions of the market include the United States, EU-4, the United Kingdom, and Japan.
There are various types such as patchy alopecia areata, alopecia totalis, alopecia universalis, diffuse alopecia areata, and ophiasis alopecia, among others.
It can be diagnosed by trichoscopy and skin biopsy, and others.
The treatments for alopecia areata can be divided into medical and natural, among others.
Different routes of administration include oral and parenteral, among others.
End users in the market include hospitals and specialty clinics, among others.
Key players involved in the market are Johnson & Johnson Services, Inc, Merck & Co., Inc., Cipla Limited, GlaxoSmithKline plc, Viatris Inc., Pfizer, Inc., Curallux, LLC., Apira Science Inc., Revian Inc., Theradome, Bausch Health Companies Inc., Perrigo Company plc, LEO Pharma A/S, Hikma Pharmaceuticals PLC, and Baxter.
Purchase Full Report
Datasheet
- Selected Sections, One User
- Printing Not Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Single User License
One User
- All Sections, One User
- One Print Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
Five Users
- All Sections, Five Users
- Five Prints Allowed
- Email Delivery in PDF
- Free Limited Customisation
- Post Sales Analyst Support
50% Discount on Next Update
Corporate License
Unlimited Users
- All Sections, Unlimited Users
- Unlimited Prints Allowed
- Email Delivery in PDF + Excel
- Free Limited Customisation
- Post Sales Analyst Support
- 50% Discount on Next Update
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Subscribe to our Newsletter
By subscribing you agree to with our privacy policy and provide
consent to
receive
updates
from our company.
Our Offices
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124